Charles River Laboratories International, Inc. Common Stock (NY:CRL)

300.30 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

These S&P500 stocks are moving in today's pre-market session ↗

December 03, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Charles River Laboratories to Present at Evercore Healthcare Conference

December 01, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

These S&P500 stocks are moving in today's session ↗

November 28, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

November 24, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

November 17, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest

November 16, 2025

Looking back on drug development inputs & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

5 Must-Read Analyst Questions From Charles River Laboratories’s Q3 Earnings Call

November 12, 2025

Charles River Laboratories’ third quarter results were met with negative market reaction, as investors focused on the company’s muted top-line growth and margin pressures. Management cited ongoing...

Via StockStory

Topics Earnings

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

3 Healthcare Stocks We Approach with Caution

November 09, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility

November 07, 2025

Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

This Charles River Laboratories Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

November 06, 2025

Via Benzinga

Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗

November 06, 2025

Via Benzinga

CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook

November 06, 2025

Lab services company Charles River Laboratories (NYSE:CRL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.00 billion. Its non-GAAP profit...

Via StockStory

Charles River (CRL) Q3 2025 Earnings Transcript ↗

November 05, 2025

Charles River (CRL) Q3 2025 Earnings Transcript

Via The Motley Fool

Charles River Beat Expectations But Why Is The Stock Falling? ↗

November 05, 2025

Charles River stock dips as Q3 revenue slips, EPS beats estimates, and company raises 2025 outlook with cost cuts and $1 billion buyback plan.

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

November 05, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Why Charles River Laboratories (CRL) Shares Are Getting Obliterated Today

November 05, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) fell 5.8% in the morning session after the company reported third-quarter results that revealed significant underlying weaknesses.

Via StockStory

Topics Artificial Intelligence

Wednesday's session: gap up and gap down stock in the S&P500 index ↗

November 05, 2025

Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Charles River Laboratories (NYSE:CRL) Tops Q3 Earnings Estimates Despite Flat Revenue ↗

November 05, 2025

Charles River Labs Q3 earnings beat estimates with $2.43 EPS. The company raised its full-year EPS guidance while navigating a slight revenue decline.

Via Chartmill

Topics Earnings

Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue

November 05, 2025

Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share...

Via StockStory

Charles River Laboratories Provides Update on Strategic Review

November 05, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Announces Third-Quarter 2025 Results

November 05, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings

November 03, 2025

Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

October 27, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 24, 2025

From Halper Sadeh LLC

Via Business Wire

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

October 22, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

October 20, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Discover which S&P500 stocks are making waves on Thursday. ↗

October 16, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Via Chartmill

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

October 15, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.